← Back to catalogue
Biportal Laminoscope, ocular
EUDAMEDClass IIa (EU MDR)
Ref BS4030175O-4K
by Joimax GmbH
Identity
- Trade Name
- Biportal Laminoscope, ocular EUDAMED
- Device Name
- joimax® Arthroscope Combo EUDAMED
- Model / Reference
- BS4030175O-4K EUDAMED
Identifiers
- Primary DI / UDI-DI
- 04250337120643 EUDAMED
- Basic UDI-DI
- 42503371ENSCARTFV EUDAMED
- Direct Marketing DI
- 04250337120643 EUDAMED
- EMDN Code
- Z12021199 ORTHOPAEDIC ENDOSCOPY INSTRUMENTS - OTHER EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- Germany EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Category: Rigid endoscope obturator
Biportal Laminoscope, ocular by Joimax GmbH — Class IIa — MDR — listed in EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Rigid endoscope obturator.
- Arthroscopy bridge — SOPRO-COMEG GmbH · Class II
- TAUT — TELEFLEX INCORPORATED · Class II
- Hysteroscopy obturator — SOPRO-COMEG GmbH · Class II
- Spinal surgery spongiosa pushers — Richard Wolf GmbH · Class I
- USA Elite — Gyrus Acmi, Inc. · Class II
- Trabecular Metal® — Zimmer, Inc. · Class I
- SHARK — Richard Wolf GmbH · Class II
- Obturator — SOPRO-COMEG GmbH · Class II
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 42503371ENSCARTFV | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Joimax GmbH
- EUDAMED SRN
- DE-MF-000009201
Sources (1)
- EUDAMED 953c80a5-4c4a-4f66-b78d-20dcd98fe29e 61 fields · synced Jun 18, 2026